Literature DB >> 33504580

Metabolic Codependencies in the Tumor Microenvironment.

Prasenjit Dey1,2, Alec C Kimmelman3, Ronald A DePinho4.   

Abstract

Metabolic reprogramming enables cancer cell growth, proliferation, and survival. This reprogramming is driven by the combined actions of oncogenic alterations in cancer cells and host cell factors acting on cancer cells in the tumor microenvironment. Cancer cell-intrinsic mechanisms activate signal transduction components that either directly enhance metabolic enzyme activity or upregulate transcription factors that in turn increase expression of metabolic regulators. Extrinsic signaling mechanisms involve host-derived factors that further promote and amplify metabolic reprogramming in cancer cells. This review describes intrinsic and extrinsic mechanisms driving cancer metabolism in the tumor microenvironment and how such mechanisms may be targeted therapeutically. SIGNIFICANCE: Cancer cell metabolic reprogramming is a consequence of the converging signals originating from both intrinsic and extrinsic factors. Intrinsic signaling maintains the baseline metabolic state, whereas extrinsic signals fine-tune the metabolic processes based on the availability of metabolites and the requirements of the cells. Therefore, successful targeting of metabolic pathways will require a nuanced approach based on the cancer's genotype, tumor microenvironment composition, and tissue location. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 33504580      PMCID: PMC8102306          DOI: 10.1158/2159-8290.CD-20-1211

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  179 in total

1.  Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.

Authors:  Caroline Bouchard; Judith Marquardt; Alexandra Brás; René H Medema; Martin Eilers
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

2.  Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.

Authors:  Sinéad E Keating; Vanessa Zaiatz-Bittencourt; Roisín M Loftus; Ciara Keane; Kiva Brennan; David K Finlay; Clair M Gardiner
Journal:  J Immunol       Date:  2016-02-12       Impact factor: 5.422

Review 3.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

4.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

5.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

Authors:  R Feinstein; H Kanety; M Z Papa; B Lunenfeld; A Karasik
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

6.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Authors:  Kirsten L Bryant; Clint A Stalnecker; Daniel Zeitouni; Jennifer E Klomp; Sen Peng; Andrey P Tikunov; Venugopal Gunda; Mariaelena Pierobon; Andrew M Waters; Samuel D George; Garima Tomar; Björn Papke; G Aaron Hobbs; Liang Yan; Tikvah K Hayes; J Nathaniel Diehl; Gennifer D Goode; Nina V Chaika; Yingxue Wang; Guo-Fang Zhang; Agnieszka K Witkiewicz; Erik S Knudsen; Emanuel F Petricoin; Pankaj K Singh; Jeffrey M Macdonald; Nhan L Tran; Costas A Lyssiotis; Haoqiang Ying; Alec C Kimmelman; Adrienne D Cox; Channing J Der
Journal:  Nat Med       Date:  2019-03-04       Impact factor: 53.440

7.  Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.

Authors:  Benjamin D Hopkins; Chantal Pauli; Xing Du; Diana G Wang; Xiang Li; David Wu; Solomon C Amadiume; Marcus D Goncalves; Cindy Hodakoski; Mark R Lundquist; Rohan Bareja; Yan Ma; Emily M Harris; Andrea Sboner; Himisha Beltran; Mark A Rubin; Siddhartha Mukherjee; Lewis C Cantley
Journal:  Nature       Date:  2018-07-04       Impact factor: 49.962

Review 8.  Genetics and biology of pancreatic ductal adenocarcinoma.

Authors:  Haoqiang Ying; Prasenjit Dey; Wantong Yao; Alec C Kimmelman; Giulio F Draetta; Anirban Maitra; Ronald A DePinho
Journal:  Genes Dev       Date:  2016-02-15       Impact factor: 11.361

9.  Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis.

Authors:  Craig Ramirez; Andrew D Hauser; Emily A Vucic; Dafna Bar-Sagi
Journal:  Nature       Date:  2019-12-11       Impact factor: 49.962

10.  KRAS4A directly regulates hexokinase 1.

Authors:  Caroline R Amendola; James P Mahaffey; Seth J Parker; Ian M Ahearn; Wei-Ching Chen; Mo Zhou; Helen Court; Jie Shi; Sebastian L Mendoza; Michael J Morten; Eli Rothenberg; Eyal Gottlieb; Youssef Z Wadghiri; Richard Possemato; Stevan R Hubbard; Allan Balmain; Alec C Kimmelman; Mark R Philips
Journal:  Nature       Date:  2019-12-11       Impact factor: 49.962

View more
  22 in total

Review 1.  Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing.

Authors:  Rilan Bai; Jiuwei Cui
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 2.  The Regulatory Roles of Mitochondrial Calcium and the Mitochondrial Calcium Uniporter in Tumor Cells.

Authors:  Linlin Zhang; Jingyi Qi; Xu Zhang; Xiya Zhao; Peng An; Yongting Luo; Junjie Luo
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 3.  The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer.

Authors:  Yuuki Ohara; Paloma Valenzuela; S Perwez Hussain
Journal:  Trends Cancer       Date:  2022-05-05

Review 4.  Pyroptosis, metabolism, and tumor immune microenvironment.

Authors:  Tiantian Du; Jie Gao; Peilong Li; Yunshan Wang; Qiuchen Qi; Xiaoyan Liu; Juan Li; Chuanxin Wang; Lutao Du
Journal:  Clin Transl Med       Date:  2021-08

Review 5.  Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis.

Authors:  SeungHye Han; Navdeep S Chandel
Journal:  Am J Respir Cell Mol Biol       Date:  2021-08       Impact factor: 6.914

Review 6.  Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer progression and metastasis.

Authors:  Xiujing Yu; Shuyi Mi; Jun Ye; Guochun Lou
Journal:  J Cancer       Date:  2021-11-04       Impact factor: 4.207

Review 7.  Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma.

Authors:  Taiana Campos Leite; Rebecca Jean Watters; Kurt Richard Weiss; Giuseppe Intini
Journal:  J Transl Med       Date:  2021-10-29       Impact factor: 5.531

8.  Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.

Authors:  Wei Zhang; Chunai Gong; Ziqiang Chen; Ming Li; Yuping Li; Jing Gao
Journal:  J Nanobiotechnology       Date:  2021-10-24       Impact factor: 10.435

Review 9.  Genetic and biological hallmarks of colorectal cancer.

Authors:  Jiexi Li; Xingdi Ma; Deepavali Chakravarti; Shabnam Shalapour; Ronald A DePinho
Journal:  Genes Dev       Date:  2021-06       Impact factor: 11.361

Review 10.  Cancer metabolism: looking forward.

Authors:  Inmaculada Martínez-Reyes; Navdeep S Chandel
Journal:  Nat Rev Cancer       Date:  2021-07-16       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.